Internal Medicine, Rheumatology · Poughkeepsie, NY
NPI
1669499018
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
30 Columbia St
Poughkeepsie, NY, 12601
Phone (845) 231-5600
Groups this clinician bills Medicare through
Medicare paid, 2024
$989K
106,053 services
Medicare patients, 2024
572
Average age 72
Drug cost, 2024
$8.6M
6,585 prescriptions
Company payments, 2025
$169
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maryanne Wysell was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 41,600 times for 12 patients. In total Maryanne Wysell billed 106,053 services in 90 codes, and Medicare paid $989K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-11-23.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 41,600 | 12 | $3.61 | $150K |
| Q5119 Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | Office | 3,000 | 12 | $15.99 | $48K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,821 | 63 | $0.10 | $284 |
| J0897 Injection, denosumab, 1 mg | Office | 1,740 | 18 | $20.80 | $36K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,654 | 16 | $0.22 | $366 |
| J7325 Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | Office | 1,248 | 13 | $7.08 | $8,842 |
| 99214 Office E&M - Established | Office | 863 | 473 | $94.26 | $81K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 663 | 398 | $13.09 | $8,681 |
| 36415 Venipuncture Blood Collection | Office | 481 | 279 | $8.60 | $4,135 |
| 80053 Clinical Chemistry | Office | 327 | 212 | $10.35 | $3,384 |
| 85025 Blood Count | Office | 297 | 192 | $7.61 | $2,260 |
| 96372 Injection Administration | Office | 264 | 49 | $11.52 | $3,042 |
| 86140 Clinical Chemistry | Office | 243 | 164 | $5.07 | $1,232 |
| 85652 Clinical Chemistry | Office | 239 | 161 | $2.64 | $631 |
| 96367 Intravenous Infusion, Hydration | Office | 208 | 35 | $23.23 | $4,831 |
By year: 2022 $1.1M for 94,431 services; 2023 $1.1M for 99,034 services; 2024 $989K for 106,053 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 481 | 279 | $8.60 | $4,135 |
| 80053 Clinical Chemistry | 327 | 212 | $10.35 | $3,384 |
| 85025 Blood Count | 297 | 192 | $7.61 | $2,260 |
| 86140 Clinical Chemistry | 243 | 164 | $5.07 | $1,232 |
| 85652 Clinical Chemistry | 239 | 161 | $2.64 | $631 |
| 82306 Clinical Chemistry | 128 | 99 | $28.81 | $3,688 |
| 82043 Clinical Chemistry | 99 | 70 | $5.66 | $560 |
| 82570 Clinical Chemistry | 88 | 62 | $5.08 | $447 |
| 81003 Clinical Chemistry | 68 | 51 | $2.20 | $150 |
| 82550 Clinical Chemistry | 65 | 47 | $6.38 | $415 |
Medicare prescription drug claims, 2024
In 2024, the drug Maryanne Wysell prescribed most often to Medicare patients was Duloxetine Hcl, with 685 prescriptions and refills. In total Maryanne Wysell wrote 6,585 Medicare prescriptions that cost $8.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Duloxetine Hcl Generic | 685 | 1,512 | 177 | $25K |
| Hydroxychloroquine Sulfate Generic | 618 | 1,282 | 148 | $25K |
| Methotrexate Methotrexate Sodium | 612 | 1,283 | 145 | $16K |
| Gabapentin Generic | 574 | 1,159 | 180 | $15K |
| Prednisone Generic | 530 | 692 | 181 | $6,416 |
| Pregabalin Generic | 365 | 455 | 56 | $15K |
| Leflunomide Generic | 210 | 436 | 54 | $12K |
| Meloxicam Generic | 147 | 325 | 52 | $1,081 |
| Mycophenolate Mofetil Generic | 118 | 212 | 32 | $13K |
| Humira(Cf) Pen Adalimumab | 118 | 150 | 21 | $1.7M |
| Celecoxib Generic | 115 | 197 | 26 | $4,750 |
| Enbrel Sureclick Etanercept | 112 | 170 | 20 | $1.3M |
| Azathioprine Generic | 110 | 187 | 21 | $3,401 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 109 | 109 | 17 | $3,025 |
| Xeljanz Xr Tofacitinib Citrate | 101 | 131 | 14 | $749K |
Brand drugs: - claims; generic drugs: 5,518 claims; opioid claims: 390.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maryanne Wysell $169 ($169 in general payments such as food, travel and fees) from 2 companies. The largest payer was Novartis Pharmaceuticals Corporation with $143.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.